These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8223403)

  • 61. Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy.
    Murti KG; Webster RG
    Virology; 1986 Feb; 149(1):36-43. PubMed ID: 3511607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses.
    Barman S; Ali A; Hui EK; Adhikary L; Nayak DP
    Virus Res; 2001 Sep; 77(1):61-9. PubMed ID: 11451488
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin.
    Atassi MZ; Webster RG
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):840-4. PubMed ID: 6187004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.
    Laver WG
    Adv Exp Med Biol; 1985; 185():149-74. PubMed ID: 3907308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis.
    Selimova LM; Zaides VM; Zhdanov VM
    J Virol; 1982 Nov; 44(2):450-7. PubMed ID: 7143574
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Properties of an antigenic glycoprotein isolated from influenza virus hemagglutinin.
    Eckert EA
    J Virol; 1973 Feb; 11(2):183-92. PubMed ID: 4688702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.
    Arora DJ; Houde M; Justewicz DM; Mandeville R
    J Virol; 1984 Dec; 52(3):839-45. PubMed ID: 6387178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus.
    Talbot PJ; Knobler RL; Buchmeier MJ
    J Immunol Methods; 1984 Oct; 73(1):177-88. PubMed ID: 6208281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serological cross-reactions between the hemagglutinin subunits of H0N1 and H1N1 influenza viruses detected with "monospecific" antisera.
    Baker N; Stone HO; Webster RG
    J Virol; 1973 Jan; 11(1):137-40. PubMed ID: 4630797
    [TBL] [Abstract][Full Text] [Related]  

  • 74. M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.
    Bucher D; Popple S; Baer M; Mikhail A; Gong YF; Whitaker C; Paoletti E; Judd A
    J Virol; 1989 Sep; 63(9):3622-33. PubMed ID: 2668560
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus.
    Anderson LJ; Coombs RA; Tsou C; Hierholzer JC
    J Clin Microbiol; 1984 Jun; 19(6):934-6. PubMed ID: 6470104
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus.
    Richardson CD; Berkovich A; Rozenblatt S; Bellini WJ
    J Virol; 1985 Apr; 54(1):186-93. PubMed ID: 3838350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunoblotting.
    Litovchick L
    Cold Spring Harb Protoc; 2020 Jun; 2020(6):098392. PubMed ID: 32482904
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Production and characterization of monoclonal antibodies to porcine brain pyridoxal kinase.
    Choi SY; Kwok F; Bahn JH; Jeon SG; Ahn YK; Yoon BH; Lee BR; Choi KS; Gao GZ
    Biofactors; 1999; 10(1):35-42. PubMed ID: 10475588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective dansylation of M protein within intact influenza virions.
    Robertson BH; Bennett JC; Compans RW
    J Virol; 1982 Dec; 44(3):871-6. PubMed ID: 7176019
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles].
    Iaroslavov AA; Kaplan IV; Erokhina TN; Morozov SIu; Solov'ev AG; Leshchiner AD; Riakhnianskaia AA; Malinin AC; Stepanova LA; Kiselev OI; Atabekov IG
    Bioorg Khim; 2011; 37(4):496-503. PubMed ID: 22096992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.